Octave Specialty Group, Inc. (OSG)
NYSEFinancialsInsurance - SpecialtySnapshot 2026-09-09
$5.01+1.21%
Close 2026-09-09 · 1-day change
NYSEFinancialsInsurance - SpecialtySnapshot 2026-09-09
Broken: Primary pillar broken — Continue positive earnings trend: EPS -4.0% vs 45.0% target.
Octave Specialty Group is growing revenue strongly, from $66.6M in 2025-Q2 to $104.17M in 2026-Q1. The company has beaten earnings estimates multiple times recently. Analysts expect revenue growth of about 25% next year. These show progress toward a stable and growing business.
The company is still loss-making and has volatile management. Free cash flow yield is negative at -17%. The business faces risks from new financial obligations and legal changes. Revenue growth may slow or profits may not materialize.
The market expects about 25% revenue growth next year. Our view aligns with this but remains cautious due to the company's loss-making status and volatile outlook.
Breaks if: Free cash flow yield remains below -10% after next 4 quarters
Breaks if: EPS falls below $0.30 in FY26 or below $0.60 in FY27
YoY revenue growth falls below 15% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround situation. OSG is currently loss-making but is focused on achieving strong organic growth and improving its financial metrics over the next few years.
The market appears to have priced in a significant expectations gap, suggesting that OSG is seen as cheap compared to its peers. However, the valuation remains unjustified given its recent earnings performance.
Management is on track to achieve strong organic growth, as evidenced by substantial revenue increases in their Insurance Distribution segment. However, recent financial performance has been weak, and the company faces elevated risks in the near term.
The long-term thesis hinges on OSG's ability to maintain growth momentum and improve its combined ratios. Additionally, the performance of sector bellwethers will be crucial, as their results could influence OSG's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings miss raises concerns about achieving growth targets. This miss impacts the company's ability to deliver strong organic growth in 2026.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, OSG's success will depend on its execution of growth strategies and the broader financial sector's health. Not investment advice.